nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—SLC22A5—dilated cardiomyopathy	0.481	1	CbGaD
Quinine—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.12	0.37	CbGbCtD
Quinine—SLC22A5—Furosemide—dilated cardiomyopathy	0.0877	0.269	CbGbCtD
Quinine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0481	0.148	CbGbCtD
Quinine—ABCB1—Lisinopril—dilated cardiomyopathy	0.037	0.114	CbGbCtD
Quinine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0326	0.0999	CbGbCtD
Quinine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0193	0.405	CbGeAlD
Quinine—KCNH2—endocardium—dilated cardiomyopathy	0.00996	0.209	CbGeAlD
Quinine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00809	0.17	CbGeAlD
Quinine—Quinidine barbiturate—SCN5A—dilated cardiomyopathy	0.00311	0.475	CrCbGaD
Quinine—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00311	0.0341	CcSEcCtD
Quinine—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00297	0.0326	CcSEcCtD
Quinine—Uremia—Lisinopril—dilated cardiomyopathy	0.00296	0.0324	CcSEcCtD
Quinine—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00257	0.0281	CcSEcCtD
Quinine—Quinidine—SCN5A—dilated cardiomyopathy	0.00219	0.333	CrCbGaD
Quinine—Anuria—Lisinopril—dilated cardiomyopathy	0.00214	0.0234	CcSEcCtD
Quinine—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00189	0.0207	CcSEcCtD
Quinine—Drug eruption—Furosemide—dilated cardiomyopathy	0.00162	0.0177	CcSEcCtD
Quinine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00144	0.0158	CcSEcCtD
Quinine—KCNN4—heart—dilated cardiomyopathy	0.0014	0.0294	CbGeAlD
Quinine—Azotaemia—Lisinopril—dilated cardiomyopathy	0.0014	0.0154	CcSEcCtD
Quinine—Blindness—Lisinopril—dilated cardiomyopathy	0.00135	0.0148	CcSEcCtD
Quinine—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0013	0.0142	CcSEcCtD
Quinine—Quinidine—SLC22A5—dilated cardiomyopathy	0.00126	0.192	CrCbGaD
Quinine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00125	0.0137	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0012	0.0131	CcSEcCtD
Quinine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00105	0.0115	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00101	0.0111	CcSEcCtD
Quinine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00101	0.011	CcSEcCtD
Quinine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000975	0.0107	CcSEcCtD
Quinine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000955	0.0105	CcSEcCtD
Quinine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000934	0.0102	CcSEcCtD
Quinine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000869	0.00952	CcSEcCtD
Quinine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.000838	0.0176	CbGeAlD
Quinine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000827	0.00906	CcSEcCtD
Quinine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000823	0.00902	CcSEcCtD
Quinine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00081	0.00888	CcSEcCtD
Quinine—Deafness—Furosemide—dilated cardiomyopathy	0.000808	0.00885	CcSEcCtD
Quinine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0008	0.00877	CcSEcCtD
Quinine—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.000792	0.0166	CbGeAlD
Quinine—KCNH2—myocardium—dilated cardiomyopathy	0.000789	0.0165	CbGeAlD
Quinine—SLC22A4—heart—dilated cardiomyopathy	0.000786	0.0165	CbGeAlD
Quinine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000766	0.00839	CcSEcCtD
Quinine—CHRM2—heart—dilated cardiomyopathy	0.000762	0.016	CbGeAlD
Quinine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000756	0.00829	CcSEcCtD
Quinine—Purpura—Furosemide—dilated cardiomyopathy	0.00075	0.00822	CcSEcCtD
Quinine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000747	0.00819	CcSEcCtD
Quinine—SLC22A5—myocardium—dilated cardiomyopathy	0.000745	0.0156	CbGeAlD
Quinine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000716	0.00785	CcSEcCtD
Quinine—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000708	0.0148	CbGeAlD
Quinine—Photophobia—Lisinopril—dilated cardiomyopathy	0.000701	0.00769	CcSEcCtD
Quinine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000665	0.00729	CcSEcCtD
Quinine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00066	0.00723	CcSEcCtD
Quinine—Confusional state—Spironolactone—dilated cardiomyopathy	0.000658	0.00721	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000651	0.00713	CcSEcCtD
Quinine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000639	0.00701	CcSEcCtD
Quinine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000637	0.00698	CcSEcCtD
Quinine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000617	0.00677	CcSEcCtD
Quinine—Eczema—Lisinopril—dilated cardiomyopathy	0.000603	0.00661	CcSEcCtD
Quinine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.0006	0.00658	CcSEcCtD
Quinine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000587	0.00644	CcSEcCtD
Quinine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00057	0.00625	CcSEcCtD
Quinine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00057	0.00624	CcSEcCtD
Quinine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000563	0.00618	CcSEcCtD
Quinine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000555	0.00609	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000552	0.00605	CcSEcCtD
Quinine—KCNH2—heart—dilated cardiomyopathy	0.00055	0.0115	CbGeAlD
Quinine—Renal failure—Furosemide—dilated cardiomyopathy	0.000547	0.006	CcSEcCtD
Quinine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000542	0.00594	CcSEcCtD
Quinine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000538	0.0059	CcSEcCtD
Quinine—Sweating—Furosemide—dilated cardiomyopathy	0.000534	0.00585	CcSEcCtD
Quinine—SLC22A5—heart—dilated cardiomyopathy	0.00052	0.0109	CbGeAlD
Quinine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00052	0.0057	CcSEcCtD
Quinine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000518	0.00568	CcSEcCtD
Quinine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000516	0.00566	CcSEcCtD
Quinine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000515	0.00565	CcSEcCtD
Quinine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00051	0.00559	CcSEcCtD
Quinine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000495	0.00543	CcSEcCtD
Quinine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000494	0.00541	CcSEcCtD
Quinine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00049	0.00537	CcSEcCtD
Quinine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00049	0.00537	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000488	0.00535	CcSEcCtD
Quinine—Visual impairment—Furosemide—dilated cardiomyopathy	0.000482	0.00528	CcSEcCtD
Quinine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000481	0.00527	CcSEcCtD
Quinine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000473	0.00518	CcSEcCtD
Quinine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000471	0.00986	CbGeAlD
Quinine—Asthma—Lisinopril—dilated cardiomyopathy	0.000468	0.00514	CcSEcCtD
Quinine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000467	0.00512	CcSEcCtD
Quinine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000466	0.00511	CcSEcCtD
Quinine—CYP1A1—heart—dilated cardiomyopathy	0.000465	0.00973	CbGeAlD
Quinine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000462	0.00506	CcSEcCtD
Quinine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000461	0.00505	CcSEcCtD
Quinine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000456	0.005	CcSEcCtD
Quinine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000451	0.00495	CcSEcCtD
Quinine—CYP2C9—heart—dilated cardiomyopathy	0.000447	0.00937	CbGeAlD
Quinine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000447	0.0049	CcSEcCtD
Quinine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000445	0.00488	CcSEcCtD
Quinine—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.000445	0.00932	CbGeAlD
Quinine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000438	0.0048	CcSEcCtD
Quinine—Erythema—Furosemide—dilated cardiomyopathy	0.000435	0.00477	CcSEcCtD
Quinine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000435	0.00477	CcSEcCtD
Quinine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000432	0.00473	CcSEcCtD
Quinine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000428	0.00469	CcSEcCtD
Quinine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000415	0.00455	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000414	0.00454	CcSEcCtD
Quinine—Rash—Spironolactone—dilated cardiomyopathy	0.000412	0.00451	CcSEcCtD
Quinine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000411	0.00451	CcSEcCtD
Quinine—Renal failure—Lisinopril—dilated cardiomyopathy	0.000411	0.0045	CcSEcCtD
Quinine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00041	0.00449	CcSEcCtD
Quinine—Headache—Spironolactone—dilated cardiomyopathy	0.000409	0.00448	CcSEcCtD
Quinine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000407	0.00446	CcSEcCtD
Quinine—Sweating—Lisinopril—dilated cardiomyopathy	0.0004	0.00439	CcSEcCtD
Quinine—Agitation—Furosemide—dilated cardiomyopathy	0.0004	0.00438	CcSEcCtD
Quinine—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000398	0.00832	CbGeAlD
Quinine—Vertigo—Furosemide—dilated cardiomyopathy	0.000391	0.00429	CcSEcCtD
Quinine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00039	0.00427	CcSEcCtD
Quinine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000389	0.00427	CcSEcCtD
Quinine—Nausea—Spironolactone—dilated cardiomyopathy	0.000388	0.00425	CcSEcCtD
Quinine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000382	0.00418	CcSEcCtD
Quinine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000375	0.00411	CcSEcCtD
Quinine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00037	0.00406	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000368	0.00403	CcSEcCtD
Quinine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000368	0.00403	CcSEcCtD
Quinine—Confusional state—Furosemide—dilated cardiomyopathy	0.000358	0.00392	CcSEcCtD
Quinine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000355	0.00389	CcSEcCtD
Quinine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00035	0.00383	CcSEcCtD
Quinine—Shock—Furosemide—dilated cardiomyopathy	0.000349	0.00383	CcSEcCtD
Quinine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000348	0.00382	CcSEcCtD
Quinine—Flushing—Lisinopril—dilated cardiomyopathy	0.000348	0.00382	CcSEcCtD
Quinine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000348	0.00381	CcSEcCtD
Quinine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000345	0.00378	CcSEcCtD
Quinine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000343	0.00376	CcSEcCtD
Quinine—Anorexia—Furosemide—dilated cardiomyopathy	0.000338	0.00371	CcSEcCtD
Quinine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000338	0.0037	CcSEcCtD
Quinine—Chills—Lisinopril—dilated cardiomyopathy	0.000336	0.00369	CcSEcCtD
Quinine—Hypotension—Furosemide—dilated cardiomyopathy	0.000332	0.00364	CcSEcCtD
Quinine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000329	0.0036	CcSEcCtD
Quinine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000326	0.00358	CcSEcCtD
Quinine—Erythema—Lisinopril—dilated cardiomyopathy	0.000326	0.00358	CcSEcCtD
Quinine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000309	0.00338	CcSEcCtD
Quinine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000308	0.00337	CcSEcCtD
Quinine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000307	0.00336	CcSEcCtD
Quinine—Tremor—Lisinopril—dilated cardiomyopathy	0.000306	0.00335	CcSEcCtD
Quinine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000298	0.00327	CcSEcCtD
Quinine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000293	0.00322	CcSEcCtD
Quinine—Syncope—Lisinopril—dilated cardiomyopathy	0.000293	0.00321	CcSEcCtD
Quinine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000293	0.00321	CcSEcCtD
Quinine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000292	0.0032	CcSEcCtD
Quinine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00029	0.00318	CcSEcCtD
Quinine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000288	0.00316	CcSEcCtD
Quinine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000287	0.00315	CcSEcCtD
Quinine—Urticaria—Furosemide—dilated cardiomyopathy	0.000282	0.00309	CcSEcCtD
Quinine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000281	0.00308	CcSEcCtD
Quinine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000281	0.00308	CcSEcCtD
Quinine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000278	0.00305	CcSEcCtD
Quinine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000278	0.00305	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000276	0.00303	CcSEcCtD
Quinine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000269	0.00294	CcSEcCtD
Quinine—Oedema—Lisinopril—dilated cardiomyopathy	0.000266	0.00292	CcSEcCtD
Quinine—Shock—Lisinopril—dilated cardiomyopathy	0.000262	0.00287	CcSEcCtD
Quinine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000262	0.00287	CcSEcCtD
Quinine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000261	0.00286	CcSEcCtD
Quinine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00026	0.00285	CcSEcCtD
Quinine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000259	0.00284	CcSEcCtD
Quinine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000258	0.00282	CcSEcCtD
Quinine—Asthenia—Furosemide—dilated cardiomyopathy	0.000255	0.00279	CcSEcCtD
Quinine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000254	0.00278	CcSEcCtD
Quinine—Pruritus—Furosemide—dilated cardiomyopathy	0.000251	0.00275	CcSEcCtD
Quinine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000249	0.00273	CcSEcCtD
Quinine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000243	0.00266	CcSEcCtD
Quinine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000243	0.00266	CcSEcCtD
Quinine—ABCB1—heart—dilated cardiomyopathy	0.000241	0.00506	CbGeAlD
Quinine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000238	0.0026	CcSEcCtD
Quinine—Dizziness—Furosemide—dilated cardiomyopathy	0.000235	0.00257	CcSEcCtD
Quinine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000232	0.00254	CcSEcCtD
Quinine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00023	0.00252	CcSEcCtD
Quinine—Vomiting—Furosemide—dilated cardiomyopathy	0.000226	0.00247	CcSEcCtD
Quinine—Rash—Furosemide—dilated cardiomyopathy	0.000224	0.00245	CcSEcCtD
Quinine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000224	0.00245	CcSEcCtD
Quinine—Headache—Furosemide—dilated cardiomyopathy	0.000222	0.00244	CcSEcCtD
Quinine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00022	0.00241	CcSEcCtD
Quinine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000218	0.00239	CcSEcCtD
Quinine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000212	0.00232	CcSEcCtD
Quinine—Nausea—Furosemide—dilated cardiomyopathy	0.000211	0.00231	CcSEcCtD
Quinine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000211	0.00231	CcSEcCtD
Quinine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000211	0.00231	CcSEcCtD
Quinine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000196	0.00215	CcSEcCtD
Quinine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000191	0.0021	CcSEcCtD
Quinine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000188	0.00207	CcSEcCtD
Quinine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000182	0.002	CcSEcCtD
Quinine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000176	0.00193	CcSEcCtD
Quinine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000169	0.00186	CcSEcCtD
Quinine—Rash—Lisinopril—dilated cardiomyopathy	0.000168	0.00184	CcSEcCtD
Quinine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000168	0.00184	CcSEcCtD
Quinine—Headache—Lisinopril—dilated cardiomyopathy	0.000167	0.00183	CcSEcCtD
Quinine—Nausea—Lisinopril—dilated cardiomyopathy	0.000158	0.00173	CcSEcCtD
Quinine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00012	0.0025	CbGpPWpGaD
Quinine—KCNN4—Neuronal System—RAF1—dilated cardiomyopathy	0.00012	0.0025	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000119	0.00248	CbGpPWpGaD
Quinine—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000114	0.00238	CbGpPWpGaD
Quinine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000113	0.00236	CbGpPWpGaD
Quinine—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00011	0.00229	CbGpPWpGaD
Quinine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000108	0.00226	CbGpPWpGaD
Quinine—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000108	0.00225	CbGpPWpGaD
Quinine—SLC22A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000107	0.00223	CbGpPWpGaD
Quinine—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000105	0.0022	CbGpPWpGaD
Quinine—SLC22A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000104	0.00217	CbGpPWpGaD
Quinine—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000101	0.00211	CbGpPWpGaD
Quinine—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000101	0.0021	CbGpPWpGaD
Quinine—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.0001	0.00209	CbGpPWpGaD
Quinine—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.66e-05	0.00201	CbGpPWpGaD
Quinine—GP9—Hemostasis—RAF1—dilated cardiomyopathy	9.57e-05	0.00199	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	9e-05	0.00188	CbGpPWpGaD
Quinine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	8.98e-05	0.00187	CbGpPWpGaD
Quinine—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.58e-05	0.00179	CbGpPWpGaD
Quinine—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.35e-05	0.00174	CbGpPWpGaD
Quinine—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.35e-05	0.00174	CbGpPWpGaD
Quinine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	8.33e-05	0.00174	CbGpPWpGaD
Quinine—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	8.19e-05	0.00171	CbGpPWpGaD
Quinine—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.76e-05	0.00162	CbGpPWpGaD
Quinine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	7.57e-05	0.00158	CbGpPWpGaD
Quinine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	7.28e-05	0.00152	CbGpPWpGaD
Quinine—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	7.14e-05	0.00149	CbGpPWpGaD
Quinine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7e-05	0.00146	CbGpPWpGaD
Quinine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	6.88e-05	0.00143	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.79e-05	0.00141	CbGpPWpGaD
Quinine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	6.75e-05	0.00141	CbGpPWpGaD
Quinine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.72e-05	0.0014	CbGpPWpGaD
Quinine—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	6.63e-05	0.00138	CbGpPWpGaD
Quinine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.54e-05	0.00136	CbGpPWpGaD
Quinine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.54e-05	0.00136	CbGpPWpGaD
Quinine—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	6.43e-05	0.00134	CbGpPWpGaD
Quinine—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	6.43e-05	0.00134	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.38e-05	0.00133	CbGpPWpGaD
Quinine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	6.35e-05	0.00132	CbGpPWpGaD
Quinine—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.27e-05	0.00131	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.22e-05	0.0013	CbGpPWpGaD
Quinine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.1e-05	0.00127	CbGpPWpGaD
Quinine—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.1e-05	0.00127	CbGpPWpGaD
Quinine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.08e-05	0.00127	CbGpPWpGaD
Quinine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	5.97e-05	0.00124	CbGpPWpGaD
Quinine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.96e-05	0.00124	CbGpPWpGaD
Quinine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	5.9e-05	0.00123	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.85e-05	0.00122	CbGpPWpGaD
Quinine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	5.75e-05	0.0012	CbGpPWpGaD
Quinine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	5.69e-05	0.00119	CbGpPWpGaD
Quinine—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	5.69e-05	0.00118	CbGpPWpGaD
Quinine—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.67e-05	0.00118	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	5.64e-05	0.00118	CbGpPWpGaD
Quinine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	5.57e-05	0.00116	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.56e-05	0.00116	CbGpPWpGaD
Quinine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	5.54e-05	0.00116	CbGpPWpGaD
Quinine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	5.37e-05	0.00112	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	5.3e-05	0.00111	CbGpPWpGaD
Quinine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	5.24e-05	0.00109	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.22e-05	0.00109	CbGpPWpGaD
Quinine—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	5.12e-05	0.00107	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	5.11e-05	0.00106	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	5.11e-05	0.00106	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.07e-05	0.00106	CbGpPWpGaD
Quinine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	5.01e-05	0.00104	CbGpPWpGaD
Quinine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	4.89e-05	0.00102	CbGpPWpGaD
Quinine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4.89e-05	0.00102	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	4.8e-05	0.000999	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.76e-05	0.000992	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.75e-05	0.00099	CbGpPWpGaD
Quinine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.66e-05	0.000971	CbGpPWpGaD
Quinine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	4.66e-05	0.000971	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	4.6e-05	0.000959	CbGpPWpGaD
Quinine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.59e-05	0.000955	CbGpPWpGaD
Quinine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	4.55e-05	0.000948	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	4.43e-05	0.000922	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	4.42e-05	0.000921	CbGpPWpGaD
Quinine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	4.35e-05	0.000906	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.33e-05	0.000902	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	4.16e-05	0.000867	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	4.16e-05	0.000866	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	4.12e-05	0.000858	CbGpPWpGaD
Quinine—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	4.11e-05	0.000856	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.07e-05	0.000848	CbGpPWpGaD
Quinine—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	3.95e-05	0.000824	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.93e-05	0.000819	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.89e-05	0.000811	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.89e-05	0.000811	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	3.87e-05	0.000807	CbGpPWpGaD
Quinine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	3.83e-05	0.000799	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	3.76e-05	0.000784	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	3.76e-05	0.000783	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	3.73e-05	0.000777	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.67e-05	0.000765	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.62e-05	0.000754	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.57e-05	0.000745	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.57e-05	0.000745	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	3.5e-05	0.00073	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	3.5e-05	0.00073	CbGpPWpGaD
Quinine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	3.48e-05	0.000725	CbGpPWpGaD
Quinine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	3.47e-05	0.000724	CbGpPWpGaD
Quinine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	3.45e-05	0.000719	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.32e-05	0.000692	CbGpPWpGaD
Quinine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	3.22e-05	0.000671	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	3.21e-05	0.000668	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	3.2e-05	0.000667	CbGpPWpGaD
Quinine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.12e-05	0.00065	CbGpPWpGaD
Quinine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.12e-05	0.00065	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.02e-05	0.00063	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	3.01e-05	0.000628	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	3.01e-05	0.000627	CbGpPWpGaD
Quinine—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	3e-05	0.000625	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.99e-05	0.000623	CbGpPWpGaD
Quinine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.97e-05	0.000619	CbGpPWpGaD
Quinine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.97e-05	0.000619	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.93e-05	0.00061	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.91e-05	0.000607	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.85e-05	0.000594	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	2.84e-05	0.000592	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	2.84e-05	0.000591	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.81e-05	0.000585	CbGpPWpGaD
Quinine—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.8e-05	0.000584	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	2.77e-05	0.000578	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.76e-05	0.000576	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.75e-05	0.000574	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	2.73e-05	0.000568	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	2.72e-05	0.000567	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.61e-05	0.000543	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	2.57e-05	0.000536	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.57e-05	0.000535	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	2.47e-05	0.000515	CbGpPWpGaD
Quinine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	2.47e-05	0.000514	CbGpPWpGaD
Quinine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.42e-05	0.000503	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.41e-05	0.000503	CbGpPWpGaD
Quinine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	2.38e-05	0.000496	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	2.36e-05	0.000491	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	2.33e-05	0.000485	CbGpPWpGaD
Quinine—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	2.3e-05	0.000479	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	2.28e-05	0.000474	CbGpPWpGaD
Quinine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.27e-05	0.000473	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.26e-05	0.00047	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.2e-05	0.000458	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.2e-05	0.000458	CbGpPWpGaD
Quinine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.19e-05	0.000456	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.14e-05	0.000446	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.12e-05	0.000442	CbGpPWpGaD
Quinine—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.11e-05	0.000439	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	2.11e-05	0.000439	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.1e-05	0.000438	CbGpPWpGaD
Quinine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.05e-05	0.000428	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.04e-05	0.000426	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2e-05	0.000416	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2e-05	0.000416	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.98e-05	0.000412	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.93e-05	0.000403	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.93e-05	0.000402	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.92e-05	0.0004	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.86e-05	0.000387	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.83e-05	0.00038	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.81e-05	0.000378	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.8e-05	0.000375	CbGpPWpGaD
Quinine—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.69e-05	0.000353	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.69e-05	0.000352	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.64e-05	0.000342	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.6e-05	0.000334	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.57e-05	0.000327	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.54e-05	0.00032	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.53e-05	0.000318	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.49e-05	0.00031	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.46e-05	0.000304	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.44e-05	0.0003	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.4e-05	0.000292	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.4e-05	0.000291	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.37e-05	0.000286	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.33e-05	0.000277	CbGpPWpGaD
Quinine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.33e-05	0.000276	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.3e-05	0.000271	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.28e-05	0.000267	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	0.000264	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.26e-05	0.000264	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.26e-05	0.000263	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.25e-05	0.000261	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.25e-05	0.00026	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.25e-05	0.000259	CbGpPWpGaD
Quinine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.24e-05	0.000258	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.19e-05	0.000248	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.19e-05	0.000248	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.18e-05	0.000246	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.18e-05	0.000246	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.17e-05	0.000244	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	1.14e-05	0.000238	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.14e-05	0.000237	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.13e-05	0.000236	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.13e-05	0.000234	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.1e-05	0.000228	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.08e-05	0.000225	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.06e-05	0.000221	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.03e-05	0.000214	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	1.02e-05	0.000213	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.02e-05	0.000213	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1e-05	0.000208	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	9.96e-06	0.000207	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	9.94e-06	0.000207	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.74e-06	0.000203	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	9.52e-06	0.000198	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	9.27e-06	0.000193	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.07e-06	0.000189	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	8.97e-06	0.000187	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	8.95e-06	0.000187	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.77e-06	0.000183	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.6e-06	0.000179	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	8.34e-06	0.000174	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.5e-06	0.000156	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	7.41e-06	0.000154	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.39e-06	0.000154	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	7.39e-06	0.000154	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.25e-06	0.000151	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	7.21e-06	0.00015	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	7.2e-06	0.00015	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	6.98e-06	0.000146	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	6.8e-06	0.000142	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.68e-06	0.000139	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	6.49e-06	0.000135	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	6.48e-06	0.000135	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	6.4e-06	0.000133	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	6.38e-06	0.000133	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	6.23e-06	0.00013	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	6.12e-06	0.000128	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	5.71e-06	0.000119	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	5.61e-06	0.000117	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	5.58e-06	0.000116	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	5.57e-06	0.000116	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	5.43e-06	0.000113	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	5.26e-06	0.00011	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.21e-06	0.000109	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.14e-06	0.000107	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	5.12e-06	0.000107	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.07e-06	0.000106	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	5.01e-06	0.000104	CbGpPWpGaD
Quinine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.89e-06	0.000102	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	4.61e-06	9.6e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	4.57e-06	9.52e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.45e-06	9.28e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.43e-06	9.23e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.34e-06	9.04e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.9e-06	8.14e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.44e-06	7.16e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.35e-06	6.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.04e-06	6.33e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.01e-06	6.28e-05	CbGpPWpGaD
